Lawyers for SAC Capital put a jolt into the SEC when they said accused trader Mathew Martoma had no short positions on two drug stocks and did not profit from them
In this issue, Bloomberg Businessweek focuses on the people who make a living assessing the performance of others—hedge fund managers, financial institutions, and more. Learning how they tick will help you think about where to put your money in 2013
A sprawling government investigation into insider trading keeps leading back to Cohen's SAC Capital. An inside look at the probe and where it's heading